Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen Heitzer

Showing results (71-80 of 143) with videos related to

Pageof 15
Sort By:
International Journal of Cancer|September 19, 2020
A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot studyMatthias Unseld, Jelena Belic, Kerstin Pierer, et al.
BMC Medical Genetics|December 31, 2013
Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinomaEllen Heitzer, Sigurd Lax, Ingrid Lafer, et al.
Scientific Reports|September 1, 2017
Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transitionVerena Tiran, Joerg Lindenmann, Luka Brcic, et al.
American Journal of Hematology|September 30, 2017
Residual disease detection using targeted parallel sequencing predicts relapse in cytogenetically normal acute myeloid leukemiaLukas Gaksch, Karl Kashofer, Ellen Heitzer, et al.
The Journal of Molecular Diagnostics : JMD|June 5, 2020
Assessment of Pre-Analytical Sample Handling Conditions for Comprehensive Liquid Biopsy AnalysisTeresa Gerber, Sabine Taschner-Mandl, Lisa Saloberger-Sindhöringer, et al.
Clinical Chemistry|April 22, 2015
Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS ApproachJelena Belic, Marina Koch, Peter Ulz, et al.
Advances in Experimental Medicine and Biology|October 19, 2016
mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNAJelena Belic, Marina Koch, Peter Ulz, et al.
The Journal of Molecular Diagnostics : JMD|March 24, 2024
Clinical Implementation of a Noninvasive, Multi-Analyte Droplet Digital PCR Test to Screen for Androgen Receptor AlterationsRegina Stitz, Franz Stoiber, Renè Silye, et al.
Familial Cancer|May 5, 2021
The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient managementClaire Palles, Lynn Martin, Enric Domingo, et al.
Nature Genetics|August 30, 2016
Inferring expressed genes by whole-genome sequencing of plasma DNAPeter Ulz, Gerhard G Thallinger, Martina Auer, et al.
Pageof 15

Showing results (71-80 of 143) with videos related to

Sort By:
Pageof 15
International Journal of Cancer|September 19, 2020
A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot studyMatthias Unseld, Jelena Belic, Kerstin Pierer, et al.
BMC Medical Genetics|December 31, 2013
Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinomaEllen Heitzer, Sigurd Lax, Ingrid Lafer, et al.
Scientific Reports|September 1, 2017
Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transitionVerena Tiran, Joerg Lindenmann, Luka Brcic, et al.
American Journal of Hematology|September 30, 2017
Residual disease detection using targeted parallel sequencing predicts relapse in cytogenetically normal acute myeloid leukemiaLukas Gaksch, Karl Kashofer, Ellen Heitzer, et al.
The Journal of Molecular Diagnostics : JMD|June 5, 2020
Assessment of Pre-Analytical Sample Handling Conditions for Comprehensive Liquid Biopsy AnalysisTeresa Gerber, Sabine Taschner-Mandl, Lisa Saloberger-Sindhöringer, et al.
Clinical Chemistry|April 22, 2015
Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS ApproachJelena Belic, Marina Koch, Peter Ulz, et al.
Advances in Experimental Medicine and Biology|October 19, 2016
mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNAJelena Belic, Marina Koch, Peter Ulz, et al.
The Journal of Molecular Diagnostics : JMD|March 24, 2024
Clinical Implementation of a Noninvasive, Multi-Analyte Droplet Digital PCR Test to Screen for Androgen Receptor AlterationsRegina Stitz, Franz Stoiber, Renè Silye, et al.
Familial Cancer|May 5, 2021
The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient managementClaire Palles, Lynn Martin, Enric Domingo, et al.
Nature Genetics|August 30, 2016
Inferring expressed genes by whole-genome sequencing of plasma DNAPeter Ulz, Gerhard G Thallinger, Martina Auer, et al.
Pageof 15